In a positive development, twenty individuals in Kenya who were in quarantine due to Ebola exposure have been released after completing a 21-day monitoring period. The individuals, who were associated with Kenya's first case of Ebola Bundibugyo virus disease, remained asymptomatic throughout their quarantine and underwent standard protocols, including a final health assessment and counseling on post-discharge precautions. The World Health Organization (WHO) has been assisting the Kenyan authorities with Ebola preparedness since the Democratic Republic of the Congo declared an outbreak on May 15. The WHO representative to Kenya, Dr. Neema Rusibamayila Kimambo, welcomed the release of the individuals, stating that they had helped protect their families, communities, and the country by completing their quarantine. Dr. Patrick Amoth, Kenya's director general for health, also expressed his appreciation for the community's support, urging them to welcome the released individuals warmly. The Kenyan authorities have conducted robust contact tracing, identifying and quarantining all contacts of the Ebola case, including family members, airline passengers, and medical personnel. While eight contacts developed symptoms and were confirmed positive for Ebola, they were immediately transferred to the Ebola treatment center in Nairobi. The country has reported nine confirmed Ebola cases and two deaths, with no evidence of community transmission. The WHO continues to support Kenya in its Ebola response, providing coordination, disease surveillance, contact tracing, and other essential services. The organization also commends the Kenyan authorities for their swift response to the outbreak. In related news, a clinical trial has been launched in the Democratic Republic of the Congo to evaluate the effectiveness of vaccines against the Ebola Bundibugyo virus. The trial, called TUMAINI, aims to determine if vaccines can provide protection against the disease. The trial is a crucial step towards gathering scientific data that will help policymakers make informed decisions on vaccine use and protect people in the current outbreak and future outbreaks. The trial is being led by the Congolese authorities and is integrated into the ongoing response to the outbreak. It is being managed by the National Public Health and Biomedical Research Institute. While it may take several months to obtain results, the trial is an important step towards finding a solution to the Ebola outbreak in the region.